These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4921675)

  • 1. [Tryptophan and its metabolism in schizophrenia].
    Szafranek J; Szafranek K
    Psychiatr Pol; 1970; 4(5):585-8. PubMed ID: 4921675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical and physiopathological bases of the study of tryptophan metabolism in schizophrenia].
    Dogaru C; Grecu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(2):141-50. PubMed ID: 6238390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tryptophan-nicotinic acid metabolism in psychiatric diseases].
    Chiancone FM
    Acta Vitaminol Enzymol; 1968; 22(3):111-33. PubMed ID: 4239848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of corticosteroid treatment repeated at short intervals on tryptophan-nicotinic acid pathway in man].
    Pasquariello G; Mainardi L
    Acta Vitaminol Enzymol; 1970; 24(1):11-4. PubMed ID: 5313668
    [No Abstract]   [Full Text] [Related]  

  • 5. Schizophrenia, rheumatoid arthritis and trytophan metabolism.
    Taylor WM
    J Clin Psychiatry; 1978 Jun; 39(6):499-503. PubMed ID: 659373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of indoleamines in schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary excretion of metabolites of the tryptophan-nicotinic acid line after repeated tryptophan load].
    Mainardi L; Pasquariello G; Tenconi LT
    Acta Vitaminol Enzymol; 1970; 24(1):15-9. PubMed ID: 5537412
    [No Abstract]   [Full Text] [Related]  

  • 8. Disturbances in tryptophan and serotonin metabolism in affective psychoses and schizophrenia.
    Puzyński S; Jakomow B
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):47-60. PubMed ID: 1107970
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
    Grahame-Smith DG
    Br J Pharmacol; 1971 Dec; 43(4):856-64. PubMed ID: 4261561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The biochemistry of mental disorders].
    Huttunen MO
    Duodecim; 1970; 86(24):1409-26. PubMed ID: 4323535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tryptophan-nicotinic acid metabolism in hyperthyroid subjects and various observations relative to pyridoxine administration].
    Cozzolino G
    Acta Vitaminol Enzymol; 1969; 23(5):153-63. PubMed ID: 5395583
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors which alter the metabolism of tryptophan.
    Price JM
    Med J Osaka Univ; 1968 Sep; 19(1):31-3. PubMed ID: 4886324
    [No Abstract]   [Full Text] [Related]  

  • 13. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of tryptophan-nicotinic acid metabolism and the blood levels of ceruloplasmin and transferrin during pregnancy and treatment with contraceptives or estrogens].
    Meani A; Cartei G
    Acta Vitaminol Enzymol; 1970; 24(6):231-5. PubMed ID: 5537937
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenia, a disorder of tryptophan metabolism.
    Gilka L
    Acta Psychiatr Scand Suppl; 1975; 258():1-83. PubMed ID: 1056684
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in serum tryptophan and albumin binding of tryptophan in chlorpromazine-treated chronic schizophrenics on withdrawal and restoration of drug therapy.
    Bender DA; Pigache RM; Gruzelier J; Hammond N
    Psychol Med; 1975 Nov; 5(4):397-403. PubMed ID: 1197542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J
    Postepy Hig Med Dosw; 1973; 27(6):725-80. PubMed ID: 4589208
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of monoamine oxidase inhibition.
    Pare CM
    Adv Biochem Psychopharmacol; 1972; 5():441-4. PubMed ID: 5054212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 20. Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia.
    Ban TA; Lehmann HE; Klingner A
    Int J Clin Pharmacol; 1973 Feb; 7(1):44-7. PubMed ID: 4699383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.